Dr. Winder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 W Grand Blvd
Detroit, MI 48202Phone+1 313-916-2600
Education & Training
- University of Michigan School of Public HealthMSc, Clinical Research Design and Statistical Analysis , 2015 - 2017
- University of MichiganFellowship, Consultation-Liaison Psychiatry, 2014 - 2015
- University of MichiganChief Residency, Psychiatry, 2013 - 2014
- University of MichiganResidency, Psychiatry, 2010 - 2014
- University of Utah School of MedicineClass of 2010
- University of UtahB.A., Behavioral Science and Health, Cum Laude, 2003 - 2005
Certifications & Licensure
- MI State Medical License 2014 - 2027
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Psychosomatic Medicine
Awards, Honors, & Recognition
- Patient Advocacy Award University of Michigan, 2015
- Certificate of Recognition, Excellence in Clinical Care University of Michigan, 2015
- Certificate of Recognition, Formation of Transplant Psychiatry Clinic University of Michigan, 2015
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- The burden of alcohol and substance use disorders in adolescents and young adults.Pojsakorn Danpanichkul, Kwanjit Duangsonk, Luis Antonio Díaz, Vincent L Chen, Pooja Rangan
Drug and Alcohol Dependence. 2024-11-14 - Enhancing alcohol use disorder care in alcohol-associated liver disease: Patient perspectives and systemic barriers.Hanna Blaney, Gerald Scott Winder, Suthat Liangpunsakul
Alcohol, Clinical & Experimental Research. 2024-11-01 - Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies.Kinza Tareen, Erin G Clifton, Ponni Perumalswami, Jessica L Mellinger, Gerald Scott Winder
Clinics in Liver Disease. 2024-11-01
Journal Articles
- Depression and frailty in patients with end-stage liver disease referred for transplant evaluationCron, D, Friedman J, Winder GS, Thelen A, Derck J, Fakhoury K, Gerebics A, Englesbe M, Sonnenday C, American Journal of Transplantation, 1/28/2015
- Preventing drinking relapse in Patients with alcoholic liver diseaseWinder GS, Mellinger J, Fontana R, Current Psychiatry, 1/1/2015
- Veterans’ use of designer cathinones and cannabinoidsWinder GS, Stilger B, Ehrnstom C, Hosanagar A, Federal Practitioner, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Psychosis By Design: Considering the Effects of Synthetic Cathinones and CannabinoidsWinder GS, Stilger B, Hosanagar A, Annual Meeting of the Academy of Psychosomatic Medicine; Annual Meeting of the Michigan Psychiatric Society, Charleston, SC, 2013; Detroit, MI, 2014, 1/16/2014
- Age of First Substance Use as a Predictor of Treatment CompletionWinder GS, Burrow-Sanchez J, Lundberg K, University of Utah Medical Student Research Symposium, Deer Valley, UT, 1/27/2007
- Differences in Bone Ultrasound Between Infants and ChildrenWinder GS, Chan G, Naught T, 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, TN, 1/24/2005
Lectures
- The Effects of Cannabis on Inpatient Agitation, Aggression, and Length-of-Stay in Patients with Schizophrenia, Schizoaffective Disorder, and Bipolar DisorderAnn Arbor, MI - 1/13/2015
- Role of Psychiatry in Liver TransplantationAnn Arbor, MI - 1/10/2015
- Psychiatry in Liver Transplant CandidatesAnn Arbor, MI - 1/10/2015
- Join now to see all
Professional Memberships
- Academy of Psychosomatic MedicineMember
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: